Clinical Trial Update: A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya. [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety and immunogenicity of a new Ebola vaccine in adults in Kilifi, Kenya.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• New Ebola vaccine

Snippet

Sponsor: University of Oxford | Conditions: Ebola Virus Disease | Phase 1 | Status: UNKNOWN